Get all your news in one place.
100's of premium titles.
One app.
Start reading
StockNews.com
StockNews.com
Business
Anushka Mukherjee

AMGN Earnings Spotlight: Analyzing Potential Gains

Boasting a strong market cap of $172.96 billion, Amgen Inc. (AMGN) specializes in the discovery, development, manufacturing, and distribution of human therapeutics worldwide. The company’s extensive product portfolio is dedicated to addressing diverse medical needs, spanning oncology, cardiovascular disease, and bone health.

AMGN is slated to announce its fourth quarter and full year 2023 financial results on Tuesday, February 6, 2024. Analysts project a significant 18.5% year-over-year growth for revenue to reach $8.11 billion in the fourth quarter. Similarly, the company's EPS for the same quarter is expected to climb 12.3% year-over-year to $4.59.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.